Supply of Additional Pharmaceutical Products (Future IDIQ Orders)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract, issued by the Defense Logistics Agency under the Department of Defense, focuses on the supply of additional pharmaceutical products through future task orders under an Indefinite Delivery, Indefinite Quantity framework. The agreement requires the contractor to maintain licensed distribution capabilities and strictly adhere to DLA packaging and logistics standards to ensure the safe and efficient delivery of medical supplies. Classified under NAICS code 424210, the contract is designed to support ongoing pharmaceutical needs for the agency. The procurement process is managed through the DLA's awarding systems, ensuring that all deliverables meet federal specifications for pharmaceutical distribution and government logistics requirements.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D226F3282.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
EPINEPHRINE INJECTION
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
